Mark-Andre Freyberg
Keine laufenden Positionen mehr
Profil
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Ehemalige bekannte Positionen von Mark-Andre Freyberg
| Unternehmen | Position | Ende |
|---|---|---|
| BIOXXMED AG | Chief Executive Officer | 30.09.2021 |
TemplaTech GmbH
 TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | President | 03.09.2007 |
| Dermatools Biotech GmbH | Founder | - |
| Cytopharma GmbH | Founder | - |
| Technische Universität Darmstadt | Corporate Officer/Principal | - |
Ausbildung von Mark-Andre Freyberg
| Technische Universität Darmstadt | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOXXMED AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | Health Technology |
| Dermatools Biotech GmbH | |
| Cytopharma GmbH |
